Document is current
Any future updates will be listed below
-
Authors
Zhang, Meng https://orcid.org/0000-0003-1042-6294
Sjöström, Martin https://orcid.org/0000-0002-2629-9966
Cui, Xiekui
Foye, Adam
Farh, Kyle
Shrestha, Raunak https://orcid.org/0000-0002-1144-1413
Lundberg, Arian https://orcid.org/0000-0002-6630-2787
Dang, Ha X. https://orcid.org/0000-0002-9342-9249
Li, Haolong
Febbo, Phillip G. https://orcid.org/0000-0002-6496-4664
Aggarwal, Rahul
Alumkal, Joshi J. https://orcid.org/0000-0003-1278-0166
Small, Eric J.
,
Aggarwal, Rahul
Alumkal, Joshi J. https://orcid.org/0000-0003-1278-0166
Feng, Felix Y. https://orcid.org/0000-0002-0963-7687
Foye, Adam
Quigley, David A. https://orcid.org/0000-0002-4726-1473
Small, Eric J.
Maher, Christopher A. https://orcid.org/0000-0002-9035-603X
Feng, Felix Y. https://orcid.org/0000-0002-0963-7687
Quigley, David A. https://orcid.org/0000-0002-4726-1473
-
Funding
Funding for this research was provided by:
Prostate Cancer Foundation
- License Information
-
More Information
Article History
Received: 13 February 2023
Accepted: 11 May 2024
First Online: 13 June 2024
Competing interests
: J.J.A. has consulted for or held advisory roles at Astellas Pharma, Bayer and Janssen Biotech Inc. He has received research funding from Aragon Pharmaceuticals Inc., Astellas Pharma, Novartis, Zenith Epigenetics Ltd. and Gilead Sciences Inc. F.Y.F. has consulted for Astellas, Bayer, Blue Earth Diagnostics, BMS, EMD Serono, Exact Sciences, Foundation Medicine, Janssen Oncology, Myovant, Roivant and Varian, and serves on the Scientific Advisory Board for BlueStar Genomics and SerImmune. F.Y.F. has patent applications with Decipher Biosciences on molecular signatures in PCa unrelated to this work. F.Y.F. has a patent application licensed to PFS Genomics/Exact Sciences. F.Y.F. has patent applications with Celgene unrelated to this work. The remaining authors declare no competing interests.
